Keyphrases
Body Mass Index
100%
Ovarian Cancer
100%
Group Studies
100%
Gynecologic Oncology Group
100%
Obese Women
100%
Carboplatin Dosing
100%
Carboplatin
62%
Obese Patients
25%
Ovarian Cancer Patients
25%
Normal Weight
25%
Jelliffe
25%
Disease Progression
12%
Glomerular Filtration Rate
12%
Dose Reduction
12%
Platelet Count
12%
Chemotherapy
12%
Area under the Curve
12%
Hemoglobin
12%
Paclitaxel
12%
Serum Creatinine
12%
Hematocrit
12%
Group Communication Protocol
12%
Gynecologic Malignancies
12%
Subtherapeutic
12%
Drug Dosing
12%
Dose Adjustment
12%
Normal-weight Women
12%
Relative Change
12%
Low Toxicity
12%
Substandard Medicines
12%
Medicine and Dentistry
Body Mass Index
100%
Carboplatin
100%
Ovarian Cancer
100%
Gynecological Oncology
100%
Cancer
12%
Glomerular Filtration Rate
12%
Platelet
12%
Disease Exacerbation
12%
Obesity
12%
Paclitaxel
12%
Hematocrit
12%
Creatinine
12%
Drug Dose Reduction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Carboplatin
100%
Chemotherapy
14%
Obesity
14%
Disease Exacerbation
14%
Creatinine
14%
Paclitaxel
14%
Drug Dose
14%